Stay updated on Baricitinib with Topical Steroids in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Baricitinib with Topical Steroids in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Baricitinib with Topical Steroids in Atopic Dermatitis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the completed BREEZE-AD4 study is available, detailing its evaluation of baricitinib with topical corticosteroids for adults with moderate-to-severe atopic dermatitis and providing trial methods, eligibility criteria, and outcome measures.
    Difference
    100%
    Check dated 2026-11-07T13:39:54.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:21:44.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says some content may use “Super Intelligence” instead of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T15:55:30.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:49:53.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer's site revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T15:43:51.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with a minimal header and a Home button, indicating that the requested study record cannot be accessed in this view. This replaces the usual study details with an error screen.
    Difference
    23%
    Check dated 2026-09-19T19:13:02.000Z thumbnail image

Stay in the know with updates to Baricitinib with Topical Steroids in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Baricitinib with Topical Steroids in Atopic Dermatitis Clinical Trial page.